HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correlation of immunohistochemical p53 labeling index with inhibition rate in chemosensitivity test in gastric and colon cancer.

Abstract
To determine whether the expression of p53, p21, bcl-2 or Ki-67 in cancer cells is predictive of chemosensitivity, immunohistochemical examination of these factors and chemosensitivity assays were performed on colon and gastric cancer specimens. Chemosensitivity tests were performed using CDDP, 5-FU, MMC, or ADR and inhibition rate (IR) was calculated by MTT assay. Before exposure to anticancer drugs, the samples were investigated immunohistochemically for expression of the above factors and after anticancer drug exposure by TUNNEL staining, for the presence of apoptotic cells. With 5-FU and MMC, the apoptotic index was well correlated with IR, so their effects were related to apoptosis. Moreover, with these two agents, the p53 labeling index (LI) was inversely correlated with IR and p21-LI showed a good correlation with IR. We therefore concluded that immunohistochemical studies for p53 and p21 were useful for predicting the chemosensitivities of colon and gastric cancer to MMC and 5-FU.
AuthorsN Hosaka, Y Ichikawa, T Ishikawa, Y Nagashima, C Kunisaki, M Takahashi, Y Moriwaki, H Akiyama, S Yamaguchi, M Ota, S Ooki, H Ike, H Shimada
JournalAnticancer research (Anticancer Res) 2001 Jan-Feb Vol. 21 Issue 1A Pg. 229-35 ISSN: 0250-7005 [Print] Greece
PMID11299739 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • Ki-67 Antigen
  • Proto-Oncogene Proteins c-bcl-2
  • Tumor Suppressor Protein p53
  • Mitomycin
  • Doxorubicin
  • Cisplatin
  • Fluorouracil
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Cisplatin (pharmacology)
  • Colonic Neoplasms (drug therapy, metabolism, pathology)
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins (metabolism)
  • Doxorubicin (pharmacology)
  • Drug Screening Assays, Antitumor
  • Fluorouracil (pharmacology)
  • Forecasting
  • Humans
  • Immunohistochemistry
  • Ki-67 Antigen (metabolism)
  • Mitomycin (pharmacology)
  • Proto-Oncogene Proteins c-bcl-2 (metabolism)
  • Stomach Neoplasms (drug therapy, metabolism, pathology)
  • Tumor Suppressor Protein p53 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: